MPXOF (MPX International) Other Long-Term Liabilities: $1.59 Mil (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MPX International Other Long-Term Liabilities?

MPX International MPXOF -99.00% Other Long-Term Liabilities is $1.59 Mil as of Mar. 2022.

MPX International's other long-term liabilities for the quarter that ended in Mar. 2022 was $1.59 Mil.

MPX International's quarterly other long-term liabilities declined from Sep. 2021 ($1.08 Mil) to Dec. 2021 ($0.99 Mil) but then increased from Dec. 2021 ($0.99 Mil) to Mar. 2022 ($1.59 Mil).

MPX International's annual other long-term liabilities increased from Sep. 2019 ($0.00 Mil) to Sep. 2020 ($0.59 Mil) and increased from Sep. 2020 ($0.59 Mil) to Sep. 2021 ($1.08 Mil).

MPX International Other Long-Term Liabilities Related Terms

MPX International Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for MPX International's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPX International Other Long-Term Liabilities Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Other Long-Term Liabilities
0.00 0.00 0.59 1.08

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.70 1.05 1.08 0.99 1.59

MPX International Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $1.59 Mil mean?
MPX International (MPXOF) has a Other Long-Term Liabilities of $1.59 Mil as of Mar. 2022. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on MPX International and its competitors.
Is MPX International's Other Long-Term Liabilities too high?
MPX International's current Other Long-Term Liabilities is $1.59 Mil.
How does MPX International's Other Long-Term Liabilities compare to ZTS and CTLT?
MPX International's Other Long-Term Liabilities of $1.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on MPX International and its competitors. MPX International's current Other Long-Term Liabilities is $1.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current Other Long-Term Liabilities of $1.59 Mil. The current Other Long-Term Liabilities is $1.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For MPX International (MPXOF), the current Other Long-Term Liabilities is $1.59 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.